Boffins To Improve Usage Of Common TB Vaccine

In a new study, researchers at Saint Louis University's Centre for Vaccine Development are trying to figure out whether the standard tuberculosis vaccine used in foreign countries

Researchers at Saint Louis University's Centre for Vaccine Development are probing to find whether the "standard" tuberculosis vaccine (used in foreign countries) offers better protection as a shot, drink or combination of both.

The "standard" tuberculosis vaccine, bacillus Calmette-Guérin (BCG), is given to infants in foreign countries, and is not currently recommended for use in the U.S.

Tuberculosis - Spread - Symptoms - Diagnosis - Treatment - FAQs
Tuberculosis, caused by Mycobacterium tuberculosis, primarily affects the lung. It may spread to other organs.

"The fight against tuberculosis is important because a third of the world is thought to be infected and there are significant problems with drug-resistant TB organisms," said Dr. Daniel Hoft, principal investigator of the study.

He added: "Experts believe it provides some protection against TB disease, particularly in children where severe manifestations of TB are averted. However, despite widespread use of BCG, TB remains a major cause of death worldwide. The main purpose of this study is to find out if BCG can be used in a more effective way.

"We hope to learn whether a BCG vaccine drink or a combination of a drink and an injection could increase immune responses against tuberculosis lung infection and affect the progression of the disease as it spreads throughout the body."

Researchers Find New Tuberculosis Vaccine To Be Safe In Its Phase I Trial
MVA85A, a leading new tuberculosis vaccine has been found to be safe in its Phase I trial.

The study will also look at whether it is better to give one or two doses of the BCG vaccine.

The research, which would require a total of 70 healthy volunteers who are 18 to 40 years old, will last about two years and requires up to 21 scheduled visits.

Inhale Your Tuberculosis Vaccine from Now!!!
A novel inhaled tuberculosis vaccine has been developed by scientists at the University of North Carolina at Chapel Hill (UNC) and Harvard that is easier to administer and store.

Each visit takes between 30 minutes and three hours, depending upon the procedures being performed.

Study participants will be compensated for their time and travel after each completed visit.

Scientists Partner to Develop and Distribute New Tuberculosis Vaccine
Bioengineers and public health researchers at Harvard University have developed a novel spraying method for delivering the most common tuberculosis (TB) vaccine.

Source-ANI
TAN